open access publication

Article, 2023

VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

Hematological Oncology, ISSN 1099-1069, 0278-0232, Volume 41, S2, Pages 58-60, 10.1002/hon.3163_25

Contributors

Al-Sawaf, Othman [1] Robrecht, Sandra [1] Zhang, Can [1] Olivieri, Stefano [2] Chang, Yi Meng [2] Fink, Anna-Maria 0000-0002-7669-7890 [1] Tausch, Eugen [3] Schneider, Christof [3] Ritgen, Matthias [4] Kreuzer, Karl-Anton [1] Sivcheva, Lylia [5] Niemann, Carsten Utoft 0000-0001-9880-5242 [6] Schwarer, Anthony P [7] Loscertales, Javier 0000-0003-3561-3758 [8] Weinkove, Robert 0000-0003-3645-7988 [9] Strumberg, Dirk [10] Kilfoyle, Allanah R [11] Runkel, Eva [12] Eichhorst, Barbara F [1] Stilgenbauer, Stephan 0000-0002-6830-9296 [3] Jiang, Yanwen [13] Hallek, Michael J 0000-0002-7425-4455 [1] Fischer, Kirsten [1]

Affiliations

  1. [1] University Hospital Cologne
  2. [NORA names: Germany; Europe, EU; OECD];
  3. [2] Roche (United Kingdom)
  4. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  5. [3] University Hospital Ulm
  6. [NORA names: Germany; Europe, EU; OECD];
  7. [4] University Hospital Schleswig-Holstein
  8. [NORA names: Germany; Europe, EU; OECD];
  9. [5] Multiprofile Hospital for Active Treatment “Hristo Botev”, Vratsa, Bulgaria
  10. [NORA names: Bulgaria; Europe, EU];

Keywords

randomization, study

Data Provider: Digital Science